C. Mancini-Terracciano
Istituto Nazionale di Fisica Nucleare, Sapienza University of Rome
Papers
2
Total Citations
16
H-Index
2
About
C. Mancini-Terracciano is a leading researcher in the field of radioguided surgery, with a specific focus on developing novel detection technologies for robotic-assisted procedures. Their primary research areas include the integration of beta-emitting PET isotopes for intraoperative guidance and the optimization of signal-to-background discrimination algorithms. Mancini-Terracciano’s major contributions center on the validation of the DROP-IN β-probe, a flexible device designed for robot-assisted radioguided surgery using receptor-targeted radiopharmaceuticals like ⁶⁸Ga-PSMA. Their first-in-human study (2024, 14 citations) defined the optimal algorithm for distinguishing tumor from healthy tissue, marking a critical step toward clinical translation. Earlier ex vivo work (2020) demonstrated the feasibility of using beta probes on prostate cancer specimens, establishing a foundation for this emerging technique. By bridging the gap between traditional gamma-probe approaches and next-generation beta-sensitive tools, Mancini-Terracciano’s research is shaping the future of precision surgery, enabling more accurate resection of tracer-avid lesions with potential applications in prostate cancer and beyond.
Research Focus
Key Achievements
Top Papers
- 1
- 2